Sign in
4

Changes in Ownership

CRESCENT BIOPHARMA, INC. Filed Acc 0001628280-26-062707

Chief Scientific Officer sold 658 shares at $17.90 ($11,778)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Pinkas Jan · Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-09-16 Sale : show line 1 in the form 10b5-1 −658 $17.90 $11,778 21,581 D
Open-market sales · 658 sh · avg $17.90 · $11,778
Loading xslF345X06/wk-form4_1789761795.xml…